Q32 Bio Ownership | Who Owns Q32 Bio?
Q32 Bio Ownership Summary
Q32 Bio is owned by 16.29% institutional investors, 6.48% insiders, and 77.22% retail investors. Orbimed advisors is the largest institutional shareholder, holding 18.47% of QTTB shares.
QTTB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Q32 Bio | 16.29% | 6.48% | 77.22% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 2.25M | 18.47% | $4.46M |
| Atlas venture life science advisors | 2.09M | 17.15% | $4.14M |
| Carlyle group | 1.10M | 9.04% | $2.13M |
| Acorn capital advisors | 803.42K | 6.59% | $1.59M |
| Arch venture management | 320.48K | 2.63% | $634.55K |
| Monaco asset management sam | 311.14K | 2.55% | $616.05K |
| Vanguard group | 295.41K | 2.42% | $584.91K |
| Pfizer | 277.78K | 2.28% | $550.00K |
| Sanofi | 244.08K | 2.00% | $483.28K |
| Trustees of columbia university in the city of new york | 133.90K | 1.10% | $265.13K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Acorn capital advisors | 803.42K | 0.81% | $1.59M |
| Atlas venture life science advisors | 2.09M | 0.55% | $4.14M |
| Sanofi | 244.08K | 0.19% | $483.28K |
| Arch venture management | 320.48K | 0.13% | $634.55K |
| Pfizer | 277.78K | 0.13% | $550.00K |
| Orbimed advisors | 2.25M | 0.11% | $4.46M |
| Carlyle group | 1.10M | 0.05% | $2.13M |
| Trustees of columbia university in the city of new york | 133.90K | 0.04% | $265.13K |
| Monaco asset management sam | 311.14K | 0.04% | $616.05K |
| Dlk investment management | 10.33K | 0.01% | $20.46K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Two sigma investments, lp | 31.51K | 0.00% | 31.51K |
| Geode capital management | 88.50K | - | 26.90K |
| Vanguard group | 295.41K | - | 25.98K |
| Hrt financial lp | 14.84K | 0.00% | 14.84K |
| Two sigma securities | 13.75K | 0.00% | 13.75K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sio capital management | - | - | -697.41K |
| Temasek (private) | - | - | -313.94K |
| Monaco asset management sam | 311.14K | 0.04% | -280.80K |
| Blackrock funding, inc. /de | 93.00K | - | -85.67K |
| Arrowmark colorado | - | - | -81.48K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma investments, lp | 31.51K | 0.00% | 31.51K | $62.38K |
| Hrt financial lp | 14.84K | 0.00% | 14.84K | $29.00K |
| Two sigma securities | 13.75K | 0.00% | 13.75K | $27.22K |
| Global retirement partners | 5.00K | 0.00% | 5.00K | $9.90K |
| Rockefeller capital management | 577.00 | - | 577.00 | $1.14K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Thompson investment management | -4.00 |
| Cbiz investment advisory services | -5.00 |
| Farther finance advisors | -6.00 |
| Bfsg | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 17 | -71.19% | 1,987,514 | -77.86% | 16 | 0.30% | 5 | -77.27% | 7 | -63.16% |
| Jun 30, 2025 | 58 | -15.94% | 8,975,903 | 22.91% | 73 | 2.05% | 22 | -12.00% | 19 | -5.00% |
| Mar 31, 2025 | 70 | -25.53% | 9,406,755 | -13.54% | 77 | 0.95% | 26 | -57.38% | 20 | 122.22% |
| Dec 31, 2024 | 95 | 33.80% | 10,995,641 | 20.72% | 91 | 1.60% | 62 | 40.91% | 9 | 12.50% |
| Sep 30, 2024 | 71 | 29.09% | 9,108,413 | 12.93% | 75 | 1.66% | 44 | 25.71% | 8 | 14.29% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 02, 2025 | Morrison Jodie Pope | CEO | Sell | $77.87K |
| Dec 02, 2025 | Kalowski Lee | CFO and President | Sell | $31.40K |
| Aug 26, 2025 | Morrison Jodie Pope | CEO | Sell | $18.90K |
| Aug 26, 2025 | Violette Shelia M. | Chief Scientific Officer | Sell | $5.38K |
| Aug 26, 2025 | Kalowski Lee | CFO and President | Sell | $7.64K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | 3 |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
QTTB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools